These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 38238369)

  • 1. CuO nanoparticles for green synthesis of significant anti-Helicobacter pylori compounds with in silico studies.
    Shehab WS; Elsayed DA; Abdel Hamid AM; Assy MG; Mouneir SM; Hamed EO; Mousa SM; El-Bassyouni GT
    Sci Rep; 2024 Jan; 14(1):1608. PubMed ID: 38238369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Helicobacter pylori Activity of Isocoumarin Paepalantine: Morphological and Molecular Docking Analysis.
    Damasceno JPL; Rodrigues RP; Gonçalves RCR; Kitagawa RR
    Molecules; 2017 May; 22(5):. PubMed ID: 28498343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polysaccharides as Bacterial Antiadhesive Agents and "Smart" Constituents for Improved Drug Delivery Systems Against Helicobacter pylori Infection.
    Menchicchi B; Hensel A; Goycoolea FM
    Curr Pharm Des; 2015; 21(33):4888-906. PubMed ID: 26290206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibacterial and antibiofilm activity of mannose-modified chitosan/PMLA nanoparticles against multidrug-resistant Helicobacter pylori.
    Arif M; Ahmad R; Sharaf M; Samreen ; Muhammad J; Abdalla M; Eltayb WA; Liu CG
    Int J Biol Macromol; 2022 Dec; 223(Pt A):418-432. PubMed ID: 36356866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An overview of nanotechnology-based treatment approaches against Helicobacter Pylori.
    Safarov T; Kiran B; Bagirova M; Allahverdiyev AM; Abamor ES
    Expert Rev Anti Infect Ther; 2019 Oct; 17(10):829-840. PubMed ID: 31591930
    [No Abstract]   [Full Text] [Related]  

  • 6. Co-administration of amoxicillin-loaded chitosan nanoparticles and inulin: A novel strategy for mitigating antibiotic resistance and preserving microbiota balance in Helicobacter pylori treatment.
    Fayed B; Jagal J; Cagliani R; Kedia RA; Elsherbeny A; Bayraktutan H; Khoder G; Haider M
    Int J Biol Macromol; 2023 Dec; 253(Pt 2):126706. PubMed ID: 37673144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eradication of Helicobacter pylori: Past, present and future.
    Lopes D; Nunes C; Martins MC; Sarmento B; Reis S
    J Control Release; 2014 Sep; 189():169-86. PubMed ID: 24969353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro antibacterial activity of nimbolide against Helicobacter pylori.
    Wylie MR; Windham IH; Blum FC; Wu H; Merrell DS
    J Ethnopharmacol; 2022 Mar; 285():114828. PubMed ID: 34763046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Residence Time-Extended Nanoparticles by Magnetic Field Improve the Eradication Efficiency of
    Yang SJ; Huang CH; Yang JC; Wang CH; Shieh MJ
    ACS Appl Mater Interfaces; 2020 Dec; 12(49):54316-54327. PubMed ID: 33236884
    [No Abstract]   [Full Text] [Related]  

  • 10. Molecular Docking and Dynamics Simulation Analysis of Thymoquinone and Thymol Compounds from
    Tabassum H; Ahmad IZ
    Med Chem; 2021; 17(2):146-157. PubMed ID: 32116195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial screening involving Helicobacter pylori of nano-therapeutic compounds based on the amoxicillin antibiotic drug.
    Hassan SS; Nader M; Nagy M; Mohamed M; Nader M; Zakaria M; Mohamed N; Waleed R; Rashidi FB
    Helicobacter; 2023 Oct; 28(5):e13004. PubMed ID: 37391943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Silico Screening and In Vitro Assessment of Natural Products with Anti-Virulence Activity against
    Spiegel M; Krzyżek P; Dworniczek E; Adamski R; Sroka Z
    Molecules; 2021 Dec; 27(1):. PubMed ID: 35011255
    [No Abstract]   [Full Text] [Related]  

  • 13. N-acetylcysteine as an adjuvant therapy for Helicobacter pylori eradication.
    Fontes LES; Martimbianco ALC; Zanin C; Riera R
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD012357. PubMed ID: 30746681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helicobacter pylori and Antibiotic Resistance, A Continuing and Intractable Problem.
    Hu Y; Zhang M; Lu B; Dai J
    Helicobacter; 2016 Oct; 21(5):349-63. PubMed ID: 26822340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highlighting the use of micro and nanoparticles based-drug delivery systems for the treatment of
    de Souza MPC; de Camargo BAF; Spósito L; Fortunato GC; Carvalho GC; Marena GD; Meneguin AB; Bauab TM; Chorilli M
    Crit Rev Microbiol; 2021 Aug; 47(4):435-460. PubMed ID: 33725462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico design and in vitro assessment of anti-Helicobacter pylori compounds as potential small-molecule arginase inhibitors.
    Fiori-Duarte AT; de Oliveira Guarnieri JP; de Oliveira Borlot JRP; Lancellotti M; Rodrigues RP; Kitagawa RR; Kawano DF
    Mol Divers; 2022 Dec; 26(6):3365-3378. PubMed ID: 34997872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Antimotilins, Novel Inhibitors of Helicobacter pylori Flagellar Motility That Inhibit Stomach Colonization in a Mouse Model.
    Suerbaum S; Coombs N; Patel L; Pscheniza D; Rox K; Falk C; Gruber AD; Kershaw O; Chhatwal P; Brönstrup M; Bilitewski U; Josenhans C
    mBio; 2022 Apr; 13(2):e0375521. PubMed ID: 35227071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential utility of nano-based treatment approaches to address the risk of
    Khan S; Sharaf M; Ahmed I; Khan TU; Shabana S; Arif M; Kazmi SSUH; Liu C
    Expert Rev Anti Infect Ther; 2022 Mar; 20(3):407-424. PubMed ID: 34658307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The molecular basis of inactivation of metronidazole-resistant Helicobacter pylori using polyethyleneimine functionalized zinc oxide nanoparticles.
    Chakraborti S; Bhattacharya S; Chowdhury R; Chakrabarti P
    PLoS One; 2013; 8(8):e70776. PubMed ID: 23951006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic therapy for Helicobacter pylori.
    Collins J; Ali-Ibrahim A; Smoot DT
    Med Clin North Am; 2006 Nov; 90(6):1125-40. PubMed ID: 17116440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.